Details of the Drug-Related molecule(s) Interaction Atlas

General Information of DTT (ID: TTUS18T)

DTT Name	IL-1 receptor-like 2 (IL1RL2) DTT Info
Gene Name	IL1RL2

Molecule-Related Drug & Molecule List

Molecule-Related Drug List

Molecule Type:

DTT

DTP

DME

Drug Status:

Approved Drug(s)

Clinical Trial Drug(s)

Download the Complete Related Drug List

1 Approved Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Spesolimab	DM9FZYT	Psoriasis vulgaris	EA90	Approved	[1]
------------------------------------------------------------------------------------

2 Clinical Trial Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Imsidolimab	DMC3FOW	Generalized pustular psoriasis	EA90.40	Phase 3	[2]
Nemvaleukin alfa	DMOAZHY	Ovarian cancer	2C73	Phase 3	[3]
------------------------------------------------------------------------------------

Molecule Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

References

1	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2	Imsidolimab, an anti-interleukin-36 receptor monoclonal antibody, for the treatment of generalized pustular psoriasis: results from the phase II GALLOP trial. Br J Dermatol. 2023 Jul 17;189(2):161-169.
3	Nemvaleukin alfa, a novel engineered IL-2 fusion protein, drives antitumor immunity and inhibits tumor growth in small cell lung cancer. J Immunother Cancer. 2022 Sep;10(9):e004913.